These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 26344678

  • 1. Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.
    Yamasaki Y, Satoh M, Mizushima M, Okazaki T, Nagafuchi H, Ooka S, Shibata T, Nakano H, Ogawa H, Azuma K, Maeda A, Tonooka K, Ito H, Takakuwa Y, Inoue M, Mitomi H, Kiyokawa T, Tsuchida K, Matsushita H, Mikage H, Murakami Y, Chan JY, Ozaki S, Yamada H.
    Mod Rheumatol; 2016; 26(3):403-9. PubMed ID: 26344678
    [Abstract] [Full Text] [Related]

  • 2. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
    Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M.
    PLoS One; 2013; 8(4):e60442. PubMed ID: 23573256
    [Abstract] [Full Text] [Related]

  • 3. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.
    Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, Loy AC, Chan EK, Reeves WH, Satoh M.
    Arthritis Rheum; 2006 Jun; 54(6):2004-9. PubMed ID: 16732549
    [Abstract] [Full Text] [Related]

  • 4. [Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody].
    Abe T, Tsunoda S, Nishioka A, Azuma K, Tsuboi K, Ogita C, Yokoyama Y, Furukawa T, Maruoka M, Tamura M, Yoshikawa T, Saito A, Sekiguchi M, Azuma N, Kitano M, Matsui K, Hosono Y, Nakashima R, Ohmura K, Mimori T, Sano H.
    Nihon Rinsho Meneki Gakkai Kaishi; 2016 Jun; 39(2):140-4. PubMed ID: 27212600
    [Abstract] [Full Text] [Related]

  • 5. Cluster Analysis Using Anti-Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis.
    Ohashi K, Sada KE, Nakai Y, Matsushima S, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Miyawaki Y, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Tatebe N, Narazaki M, Matsumoto Y, Sunahori Watanabe K, Kawabata T, Wada J.
    J Clin Rheumatol; 2019 Sep; 25(6):246-251. PubMed ID: 29933322
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T.
    PLoS One; 2015 Sep; 10(3):e0120313. PubMed ID: 25789468
    [Abstract] [Full Text] [Related]

  • 7. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis.
    Matsushita T, Hasegawa M, Fujimoto M, Hamaguchi Y, Komura K, Hirano T, Horikawa M, Kondo M, Orito H, Kaji K, Saito Y, Matsushita Y, Kawara S, Yasui M, Seishima M, Ozaki S, Kuwana M, Ogawa F, Sato S, Takehara K.
    J Rheumatol; 2007 May; 34(5):1012-8. PubMed ID: 17309126
    [Abstract] [Full Text] [Related]

  • 10. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T.
    Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis.
    Temmoku J, Sato S, Fujita Y, Asano T, Suzuki E, Kanno T, Furuya MY, Matsuoka N, Kobayashi H, Watanabe H, Koga T, Shimizu T, Kawakami A, Migita K.
    Medicine (Baltimore); 2019 May; 98(20):e15578. PubMed ID: 31096460
    [Abstract] [Full Text] [Related]

  • 13. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q.
    BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248
    [Abstract] [Full Text] [Related]

  • 16. Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.
    Xing X, Li A, Li C.
    Respir Med; 2020 Oct 12; 172():106134. PubMed ID: 32905890
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia.
    Yura H, Sakamoto N, Satoh M, Ishimoto H, Hanaka T, Ito C, Hasegawa T, Tanaka S, Miyamura T, Nakashima S, Hara A, Kakugawa T, Oda K, Kido T, Obase Y, Ishimatsu Y, Yatera K, Kawakami A, Mukae H.
    Respir Med; 2017 Nov 12; 132():189-194. PubMed ID: 29229096
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody.
    Kishaba T, McGill R, Nei Y, Ibuki S, Momose M, Nishiyama K, Nagano H, Yamashiro S.
    J Med Invest; 2018 Nov 12; 65(3.4):251-257. PubMed ID: 30282869
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease.
    Nakashima R, Hosono Y, Mimori T.
    Lupus; 2016 Jul 12; 25(8):925-33. PubMed ID: 27252271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.